Study Overview
Sakellaris et al. (2006) conducted a pilot study examining the effects of creatine supplementation in children who had sustained traumatic brain injuries (TBI). Building on preclinical evidence from Sullivan et al. (2000) showing neuroprotective effects of creatine in animal models, this was one of the first clinical studies to test creatine’s potential in human brain injury recovery (G et al., 2006) .
Key Findings
- Reduced duration of post-traumatic amnesia: Children receiving creatine showed shorter periods of post-traumatic amnesia compared to control groups
- Improved cognitive recovery: Cognitive assessment scores improved more rapidly in the creatine-supplemented group
- Shorter ICU stays: The creatine group tended to have shorter intensive care unit stays, suggesting faster stabilization
- Fewer complications: There were fewer instances of headache, dizziness, and fatigue in the creatine group during the recovery period
- Safe and well-tolerated: Creatine supplementation was well-tolerated in the pediatric population with no reported adverse effects
Practical Implications
While this study is preliminary, it opens an exciting avenue for creatine research beyond sports performance. Traumatic brain injury is a leading cause of death and disability in children worldwide, including in Malaysia where road traffic accidents remain a significant pediatric health concern. The finding that creatine may support brain recovery adds to the growing body of evidence for creatine’s neuroprotective properties. However, it is essential to note that this was a small pilot study, and creatine should not be self-administered as a TBI treatment without medical supervision. Larger, well-designed clinical trials are needed before creatine can be recommended as part of standard TBI management protocols.
Study Limitations
- Small sample size limits the statistical power and generalizability of findings
- The study was not double-blinded in the strictest sense, which could introduce bias
- Dosing protocols for pediatric TBI patients have not been optimized
- Long-term follow-up data was limited, and it is unclear whether early benefits persisted
- The control group did not receive a matched placebo in all cases
Study Design and Methodology
Understanding how a study was designed helps assess the strength of its conclusions. Key methodological factors to evaluate include:
- Sample size — larger studies (n=50+) provide more reliable results than small studies (n=10-15). Small sample sizes increase the risk of false positives and limit the ability to detect moderate effect sizes
- Study duration — creatine research requires adequate duration for muscle saturation (minimum 4 weeks for maintenance dosing, 1 week for loading). Studies shorter than this may miss the full effect
- Blinding — double-blind, placebo-controlled designs (where neither researchers nor participants know who receives creatine) are the gold standard for minimising bias
- Population studied — results from trained athletes may not fully apply to untrained individuals, and vice versa. Age, sex, and dietary habits (particularly vegetarian status) also influence creatine response
- Outcome measures — direct measures (muscle biopsy, MRS imaging) are more informative than indirect proxies (blood markers, performance tests) for assessing creatine uptake and metabolism
Clinical Implications and Practical Relevance
This research contributes to our understanding of creatine in several practical ways:
For athletes and fitness enthusiasts: The findings support the use of creatine monohydrate as a safe, effective ergogenic aid. The standard dosing protocol of 3-5g daily remains well-supported by the cumulative evidence base including this study.
For healthcare professionals: Understanding the specific mechanisms and safety data from studies like this helps clinicians provide evidence-based guidance to patients who ask about creatine supplementation. The research consistently shows a favourable safety profile at recommended doses.
For the Malaysian context: While most creatine research is conducted in Western populations, the fundamental biochemistry (ATP-phosphocreatine system) is universal. Malaysian consumers can apply these findings with confidence, adjusting for local factors like tropical climate (increased hydration needs) and halal dietary requirements (synthetic creatine monohydrate is permissible).
How This Fits Into the Broader Evidence
No single study should be used to make definitive claims about creatine supplementation. Instead, this research should be viewed as one piece of a much larger evidence base:
- The ISSN Position Stand (2017) synthesises hundreds of studies into comprehensive recommendations
- Multiple systematic reviews and meta-analyses confirm creatine’s effects on strength, power, and lean mass
- Long-term safety data spanning up to 5 years shows no adverse effects at recommended doses
For a complete overview of the evidence, explore our Research Library which covers 60+ landmark creatine studies.
Sources & References
This page summarizes Sakellaris et al. (2006). Full citation: Sakellaris G, Kotsiou M, Tamiolaki M, Kalostos G, Tsapaki E, Spanaki M, Spilioti M, Charissis G, Evangeliou A. Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration. Journal of Trauma. 2006;61(2):322-329. doi:10.1097/01.ta.0000230269.55313.ca
What This Means for You
For the average creatine user, this research supports the following practical recommendations:
- Choose creatine monohydrate — it remains the most studied and effective form
- Take 3-5g daily — consistent daily dosing is more important than timing
- Take it with food — insulin response from meals enhances muscle uptake
- Be patient — full saturation takes 3-4 weeks without loading
- Combine with exercise — creatine works best when paired with resistance or high-intensity training
For more on practical dosing strategies, see our creatine dosage guide.